TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9324175

Group type: EXPERIMENTAL
Intervention: Atropine 0.5 mg intravenously
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 8267679

Group type: EXPERIMENTAL
Intervention: Bromfenac 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bromfenac 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bromfenac 75 mg
Number of subjects: 12
Study: 3009726

Group type: EXPERIMENTAL
Intervention: Postoperative CAP chemotherapy (Cytoxan, Adriamycin, and cisplatin)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Bacillus Calmette‐Guerin (BCG) and levamisole immunotherapy
Number of subjects: 141
Study: 28751531

Group type: EXPERIMENTAL
Intervention: Soccer-specific ankle braces worn on both ankles during soccer training and matches
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual soccer play without ankle braces
Number of subjects: 0
Study: 28810359

Group type: EXPERIMENTAL
Intervention: Intervention group (text reminders and supportive counseling)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Low adherers (external regulation)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Autonomous motivation
Number of subjects: 115
Study: 26482473

Group type: EXPERIMENTAL
Intervention: Enhanced psychological training of community midwives (CMWs) providing psychological support sessions to pregnant women.
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Community midwives providing psychological support sessions.
Number of subjects: 298
Study: 24604243

Group type: EXPERIMENTAL
Intervention: Almorexant 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ketoconazole 400 mg once daily for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diltiazem 300 mg once daily for 11 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Almorexant with ketoconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Almorexant with diltiazem
Number of subjects: 0
Study: 22313564

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg dexamethasone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Oral placebo solution
Number of subjects: 70
Study: 20189654

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.3 mg
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Sham injections (control for MARINA)
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT, control for ANCHOR)
Number of subjects: 1025
Study: 18054727

Group type: EXPERIMENTAL
Intervention: Acupuncture (AC)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham Acupuncture (SAC)
Number of subjects: 21
Study: 15635348

Group type: EXPERIMENTAL
Intervention: 1,000 mg of S oblonga extract
Number of subjects: 39

Group type: COMPARATOR
Intervention: 0 mg of S oblonga extract (control)
Number of subjects: 39
Study: 12131561

Group type: EXPERIMENTAL
Intervention: Lacidipine 4 mg o.i.d.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10958373

Group type: EXPERIMENTAL
Intervention: 6.9% carbohydrate-electrolyte solution (CES)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sweetened placebo (P)
Number of subjects: 13
Study: 9026563

Group type: EXPERIMENTAL
Intervention: Serotonin in blood
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study: 1610425

Group type: EXPERIMENTAL
Intervention: Film-coated tablet
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: New enteric-coated pellet preparation
Number of subjects: 11
Study: 6703637

Group type: EXPERIMENTAL
Intervention: Ligation alone
Number of subjects: 103

Group type: COMPARATOR
Intervention: Ligation and invagination
Number of subjects: 103
Study: 30497904

Group type: EXPERIMENTAL
Intervention: SB spray
Number of subjects: 52
Study: 30107350

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg intravenous (IV) ketamine
Number of subjects: 5
Study: 26481928

Group type: EXPERIMENTAL
Intervention: Stavudine
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 480
Study: 25410451

Group type: EXPERIMENTAL
Intervention: Amitriptyline and aerobic exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amitriptyline alone
Number of subjects: 60
Study: 23082557

Group type: EXPERIMENTAL
Intervention: Nevirapine (400 mg/day)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Efavirenz (600 mg/day)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Nevirapine and Efavirenz
Number of subjects: 124
Study: 20224868

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide and bupivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (bupivacaine or triamcinolone acetonide alone)
Number of subjects: 100
Study: 18626267

Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg/d)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Clomipramine (25 mg/d)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Citalopram vs Clomipramine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Active treatment groups (Citalopram and Clomipramine)
Number of subjects: 54
Study: 15756251

Group type: EXPERIMENTAL
Intervention: Various interventions in cancer trials (specific interventions not detailed in the abstract)
Number of subjects: 520
Study: 12095510

Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching (n = 85)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Chemical-assisted hatching (n = 56)
Number of subjects: 141
Study: 10331828

Group type: EXPERIMENTAL
Intervention: Ceftazidime treatment (postintervention)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Ceftazidime treatment (preintervention)
Number of subjects: 85
Study: 7490172

Group type: EXPERIMENTAL
Intervention: Intra-articular injections of 750 mcg of somatostatin 14 (SST14) at 15-day intervals
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intra-articular injections of 750 mcg of somatostatin 14 (SST14)
Number of subjects: 16
Study: 30312272

Group type: EXPERIMENTAL
Intervention: Navigation-assisted screw fixation (NSF)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Navigation-assisted screw fixation with additional sacroplasty (NSF + SP)
Number of subjects: 52
Study: 29081428

Group type: EXPERIMENTAL
Intervention: CMIground
Number of subjects: 68

Group type: COMPARATOR
Intervention: CMIfloat
Number of subjects: 68
Study: 25617046

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mediterranean diet with Realsil complex
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 23378467

Group type: EXPERIMENTAL
Intervention: Fostamatinib 100 mg bid
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Fostamatinib 100 mg qd
Number of subjects: 457

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study: 21548951

Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Fields bone growth stimulating device (active)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Disabled Pulsed Electromagnetic Fields bone growth stimulating device (placebo)
Number of subjects: 0
Study: 19046200

Group type: EXPERIMENTAL
Intervention: Psychosocial factors (night duty, stress, administrative position)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Lower fasting plasma glucose (FPG) levels, being a white-collar worker, non-smoking, lower serum alanine aminotransferase (ALT) levels
Number of subjects: 128
Study: 15943851

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of famotidine (40 mg/day)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Drip infusion of omeprazole (40 mg/day)
Number of subjects: 400
Study: 12600912

Group type: EXPERIMENTAL
Intervention: Acetylcysteine (600 mg BID)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 10846331

Group type: EXPERIMENTAL
Intervention: 800 micrograms misoprostol vaginally at home (self-administered)
Number of subjects: 22
Study: 9387637

Group type: EXPERIMENTAL
Intervention: Breathing exercises (BE)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo medicine (Control)
Number of subjects: 324
Study: 2039616

Group type: EXPERIMENTAL
Intervention: Energy storing prosthetic feet (Seattle and Flex feet)
Number of subjects: 10

Group type: COMPARATOR
Intervention: SACH foot
Number of subjects: 10
Study: 6481116

Group type: EXPERIMENTAL
Intervention: 30 mg of prednisone (oral dose)
Number of subjects: 18
Study: 30760248

Group type: EXPERIMENTAL
Intervention: QUiPP app
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (standard management)
Number of subjects: 0
Study: 29453222

Group type: EXPERIMENTAL
Intervention: Clear lens extraction (CLE)
Number of subjects: 419
Study: 26917681

Group type: EXPERIMENTAL
Intervention: Feedback intervention (structured feedback sessions)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Routine practice (control group)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Feedback intervention
Number of subjects: 35
Study: 24367796

Group type: EXPERIMENTAL
Intervention: Biological male personnel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transgender researcher
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold pressor apparatus (ice cooler vs. refrigerated bath circulator)
Number of subjects: 0
Study: 23117776

Group type: EXPERIMENTAL
Intervention: 1 mg/kg dexamethasone
Number of subjects: 4494

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4494
Study: 20227579

Group type: EXPERIMENTAL
Intervention: Long-pulsed neodymium:yttrium-aluminium-garnet laser treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Topical benzoyl peroxide and clindamycin (Control)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Histologic examination
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Patient satisfaction assessment
Number of subjects: 22
Study: 18154905

Group type: EXPERIMENTAL
Intervention: diet/probiotics
Number of subjects: 256

Group type: COMPARATOR
Intervention: diet/placebo
Number of subjects: 256

Group type: COMPARATOR
Intervention: control/placebo
Number of subjects: 256
Study: 15943650

Group type: EXPERIMENTAL
Intervention: Individual nutrition education provided by a dietitian (6 sessions over 3 months)
Number of subjects: 51
Study: 12181386

Group type: EXPERIMENTAL
Intervention: Prednisolone (30 mg daily for 1 week)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 10338457

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 67
Study: 7574005

Group type: EXPERIMENTAL
Intervention: 0.1 MAC isoflurane with subjects in the asleep state
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0.1 MAC isoflurane with subjects in the awake state
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.1 MAC isoflurane during early hypoxia
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.1 MAC isoflurane during late hypoxia
Number of subjects: 9
Study: 1951997

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg suxamethonium
Number of subjects: 67

Group type: COMPARATOR
Intervention: 0.5 mg/kg suxamethonium
Number of subjects: 67
Study: 7019782

Group type: EXPERIMENTAL
Intervention: Sustained release indomethacin capsules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indomethacin suppositories
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral route of medication (sustained release indomethacin)
Number of subjects: 0
Study: 31451704

Group type: EXPERIMENTAL
Intervention: Rice bran extract supplement (RBS) 1,000 mg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28135891

Group type: EXPERIMENTAL
Intervention: Partial Splenic Embolization (PSE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Splenectomy
Number of subjects: 50
Study: 27523583

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: DASH diet among participants with baseline serum UA ≥7 mg/dl (n=8)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Medium sodium intake
Number of subjects: 103

Group type: COMPARATOR
Intervention: High sodium intake
Number of subjects: 103
Study: 24366395

Group type: EXPERIMENTAL
Intervention: Heart failure drugs (β-blockers, diuretics, ACEIs/ARBs)
Number of subjects: 171097
Study: 22484777

Group type: EXPERIMENTAL
Intervention: Beta-blockade (BB) therapy
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Resting HR>70 bpm
Number of subjects: 280
Study: 20488486

Group type: EXPERIMENTAL
Intervention: Voiding cystourethrography and dimercapto-succinic acid scintigraphy at study entry and 2-year follow-up
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Noninvasive methods for lower urinary tract function assessment
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Assessment of renal damage and recurrent urinary tract infections
Number of subjects: 203
Study: 18568957

Group type: EXPERIMENTAL
Intervention: Heuristic rule training for 4 hours on a PC-based simulation of a process control task
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no heuristic rule training)
Number of subjects: 39
Study: 16649872

Group type: EXPERIMENTAL
Intervention: High-dose nicotine patch (35 mg)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study: 12618645

Group type: EXPERIMENTAL
Intervention: Physician opinion leader intervention (OL)
Number of subjects: 2210

Group type: COMPARATOR
Intervention: Health Care Quality Improvement Program (HCQIP)
Number of subjects: 2210

Group type: COMPARATOR
Intervention: No intervention (NI)
Number of subjects: 2210
Study: 10373091

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention with posture correction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non‐intervention control
Number of subjects: 0
Study: 8913402

Group type: EXPERIMENTAL
Intervention: Emla cream (5%)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1365487

Group type: EXPERIMENTAL
Intervention: droxicam 20mg/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: diclofenac sodium 150mg/day
Number of subjects: 80
Study: 6341350

Group type: EXPERIMENTAL
Intervention: Cefotetan (1 or 2 g every 12 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefoxitin (1 or 2 g every 8 h)
Number of subjects: 0
Study: 30099113

Group type: EXPERIMENTAL
Intervention: 50mg diclofenac potassium
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: 20mg hyoscine-N-butyl bromide (HBB)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 30540772

Group type: EXPERIMENTAL
Intervention: Gratitude training
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Loving-kindness
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Breath awareness
Number of subjects: 156

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 156
Study: 28722480

Group type: EXPERIMENTAL
Intervention: SAR342434 (SAR-Lis)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Insulin lispro (Ly-Lis)
Number of subjects: 507
Study: 24957256

Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg daily plus best supportive care (BSC)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo plus best supportive care (BSC)
Number of subjects: 185
Study: 24257332

Group type: EXPERIMENTAL
Intervention: Conventional gravitational valves
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer duration of surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Programmable valve exchange to gravitational valve
Number of subjects: 0
Study: 20829335

Group type: EXPERIMENTAL
Intervention: Presence at the time of death
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Older patient demographics
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Early family conferences
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Withdrawal of a ventilator ordered
Number of subjects: 226
Study: 18309905

Group type: EXPERIMENTAL
Intervention: Radix astragali (RA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 10
Study: 17019683

Group type: EXPERIMENTAL
Intervention: Posterior stabilized prostheses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cruciate retaining prostheses
Number of subjects: 0
Study: 14658584

Group type: EXPERIMENTAL
Intervention: Monotherapy with platinum analogues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various combinations of cytostatic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cisplatin/bleomycin/mitomycin C/vindesine, cisplatin/paclitaxel, cisplatin/irinotecan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-fluoruracil, ifosfamide, paclitaxel, or cisplatinum
Number of subjects: 0
Study: 10720913

Group type: EXPERIMENTAL
Intervention: 1% N-chlorotaurine (NCT) applied 5 times a day
Number of subjects: 9
Study: 9061681

Group type: EXPERIMENTAL
Intervention: Treated bednets (lambdacyhalothrin 10 mg/m2)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (villages without nets)
Number of subjects: 16
Study: 8117508

Group type: EXPERIMENTAL
Intervention: Early technetium‐99m methylene diphosphonate (99mTc‐MDP) scintimetry
Number of subjects: 84

Group type: COMPARATOR
Intervention: Follow-up scintimetry after conservative treatment and osteosynthesis
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Scintimetry
Number of subjects: 84
Study: 4027120

Group type: EXPERIMENTAL
Intervention: Activated charcoal 50 g in 300 ml of water
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Activated charcoal 50 g administered immediately after PAS 10 g or 20 g
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water only (control)
Number of subjects: 6
Study: 29917069

Group type: COMPARATOR
Intervention: 0 µg/d vitamin D3
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 10 µg/d vitamin D3
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 20 µg/d vitamin D3
Number of subjects: 119
Study: 27089843

Group type: EXPERIMENTAL
Intervention: Parenteral nutritional support for 5 days (n=1200)
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Enteral nutritional support for 5 days (n=1200)
Number of subjects: 2400
Study: 25856732

Group type: EXPERIMENTAL
Intervention: Repeated pulmonary rehabilitation (PR)
Number of subjects: 106
Study: 22332940

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study: 20354718

Group type: EXPERIMENTAL
Intervention: Normoxic condition (F(I)O(2) 0.21)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Acute hypoxic condition (F(I)O(2) 0.13)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 13
Study: 18845972

Group type: EXPERIMENTAL
Intervention: Training under hypoxia (FiO2 = 15%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Training under normoxia (FiO2 = 21%)
Number of subjects: 20
Study: 16001319

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75 %
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prilocaine 1 %
Number of subjects: 40
Study: 12215595

Group type: EXPERIMENTAL
Intervention: Recent hemispheric stroke patients (left and right)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study: 10521842

Group type: EXPERIMENTAL
Intervention: Cystic hygroma (class 1)
Number of subjects: 1867

Group type: EXPERIMENTAL
Intervention: Duodenal atresia (class 2)
Number of subjects: 1867

Group type: EXPERIMENTAL
Intervention: Holoprosencephaly (class 3)
Number of subjects: 1867

Group type: EXPERIMENTAL
Intervention: Omphalocele (class 4)
Number of subjects: 1867
Study: 7475658

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg primaquine base daily (double‐blinded)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo (double‐blinded)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 300 mg chloroquine base weekly (open)
Number of subjects: 126
Study: 1942917

Group type: EXPERIMENTAL
Intervention: Solcoseryl ophthalmic gel
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 2.4% cysteine in ophthalmic gel
Number of subjects: 18
Study: 463541

Group type: EXPERIMENTAL
Intervention: Short end‐hole catheter
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Long side‐hole catheter
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Short side‐hole catheter
Number of subjects: 71

Group type: COMPARATOR
Intervention: Long end‐hole catheter
Number of subjects: 71
Study: 31347438

Group type: EXPERIMENTAL
Intervention: In-line filtration
Number of subjects: 268

Group type: COMPARATOR
Intervention: No filtration (control group)
Number of subjects: 268
Study: 31180833

Group type: EXPERIMENTAL
Intervention: Hybrid robotic system combining EMG-Triggered FES with a passive exoskeleton for upper limb suspension during a structured exercise program of 27 sessions lasting 30 min each.
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hybrid robotic system
Number of subjects: 7
Study: 28326680

Group type: EXPERIMENTAL
Intervention: Desmopressin 0.3 μg/kg administered 30 min before surgery
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal saline administered 30 min before surgery
Number of subjects: 48
Study: 25875679

Group type: EXPERIMENTAL
Intervention: Experimental RGP lens (ExpRGP)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard RGP lens (StdRGP)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No lens (baseline)
Number of subjects: 52
Study: 25007542

Group type: EXPERIMENTAL
Intervention: Active light treatment (ALT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo light treatment (L-PBO)
Number of subjects: 24
Study: 17310659

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Ayurveda
Number of subjects: 69

Group type: COMPARATOR
Intervention: Wait-list Control
Number of subjects: 69
Study: 15023808

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/d for 6 weeks, then 80 mg/d for 6 weeks, then 80 mg/d for 24 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/d for 6 weeks, then 40 mg/d for 6 weeks, then 80 mg/d for 24 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both statins
Number of subjects: 39
Study: 11029999

Group type: EXPERIMENTAL
Intervention: Safe Dates program
Number of subjects: 14